Deafness-encephaloneuropathy-obesity-valvulopathy syndrome is a rare mitochondrial disease with marked clinical variability typically characterized by encephalomyopathy, kidney disease (nephrotic syndrome), optic atrophy, early-onset deafness, pancytopenia, obesity, and cardiac disease (valvulopathy). Additionally, macrocephaly, intellectual disability, hyperlactatemia, elevated lactate/pyruvate ratio, insulin-dependent diabetes, livedo reticularis, liver dysfunction and seizures have also been associated.
Comprehensive, easy-to-understand information about this condition
Checking for content...
coenzyme Q10 deficiency, primary, 1
MONDO:0011829
autosomal recessive ataxia due to ubiquinone deficiency
MONDO:0012784
familial steroid-resistant nephrotic syndrome with sensorineural deafness
MONDO:0013836
coenzyme Q10 deficiency, primary, 3
MONDO:0013838
encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome
MONDO:0013840
neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome
MONDO:0014562